CD79A and urethra adenocarcinoma: In patients with non‐UAD EMP, Ig status was reported in 59 cases, most common being IgG (61% n = 36), followed by IgA (30.5%, n = 18), IgM (5.1%, n = 3) and IgD 2 (3.4%, n = 2).